Ticker Symbol | Entity Name | Employer Id | As Of Date | Profile Url | Name | Website | Company Type | Industry | Active Status | Employer Status | Headquarters City | Year Founded | Rating: Overall | Rating: CEO (%) | Rating: Business Outlook (%) | Rating: Recommend (%) | Rating: Compensation & Benefits | Rating: Culture & Values | Rating: Career Opportunities | Rating: Diversity and Inclusion | Rating: Work/Life Balance | Rating: Senior Management | Ratings Star 1 Count | Ratings Star 2 Count | Ratings Star 3 Count | Ratings Star 4 Count | Ratings Star 5 Count | Ratings Count | Ratings Diversity and Inclusion Count | Ratings CEO Count | Ratings Star 1 (%) | Ratings Star 2 (%) | Ratings Star 3 (%) | Ratings Star 4 (%) | Ratings Star 5 (%) | Awards Count | Job Count | Review Count | Interview Experience: Positive | Interview Experience: Neutral | Interview Experience: Negative | Interview Channel: Online (%) | Interview Channel: Campus Recruiting | Interview Channel: Recruiter | Interview Channel: Employee Referral | Interview Channel: Staffing Agency | Interview Channel: In-Person | Interview Channel: Other | CEO Profile Image | CEO | Date Added | Date Updated | Company Name | Sector | Industry | CEO Gender | CEO Ethnicity |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
nasdaq:fate | https://www.glassdoor.com?employer_id=601238 | 601238 | Apr 28th, 2024 12:00AM | Open | Fate Therapeutics | Open | Company - Public | Biotechnology | San Diego, CA | 2.60 | 25% | 16% | 31% | 3.90 | 2.70 | 2.70 | 3.30 | 2.30 | 2.30 | 23.00 | 17.00 | 11.00 | 19.00 | 9.00 | 79.00 | 73.00 | 54.00 | 29.114% | 21.519% | 13.924% | 24.051% | 11.392% | 0.00 | 107.00 | 0.35 | 0.15 | 0.50 | 0.43 | 0.36 | 0.21 | Scott Wolchko | Apr 28th, 2024 04:13PM | Apr 28th, 2024 04:13PM | Fate Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||||||||||
nasdaq:fate | https://www.glassdoor.com?employer_id=601238 | 601238 | Apr 26th, 2024 12:00AM | Open | Fate Therapeutics | Open | Company - Public | Biotechnology | San Diego, CA | 2.60 | 25% | 16% | 31% | 3.90 | 2.70 | 2.70 | 3.30 | 2.30 | 2.30 | 23.00 | 17.00 | 11.00 | 19.00 | 9.00 | 79.00 | 73.00 | 54.00 | 29.114% | 21.519% | 13.924% | 24.051% | 11.392% | 0.00 | 4.00 | 107.00 | 0.35 | 0.15 | 0.50 | 0.43 | 0.36 | 0.21 | Scott Wolchko | Apr 26th, 2024 07:59AM | Apr 26th, 2024 07:59AM | Fate Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:fate | https://www.glassdoor.com?employer_id=601238 | 601238 | Apr 25th, 2024 12:00AM | Open | Fate Therapeutics | Open | Company - Public | Biotechnology | San Diego, CA | 2.60 | 25% | 16% | 31% | 3.90 | 2.70 | 2.70 | 3.30 | 2.30 | 2.30 | 23.00 | 17.00 | 11.00 | 19.00 | 9.00 | 79.00 | 73.00 | 54.00 | 29.114% | 21.519% | 13.924% | 24.051% | 11.392% | 0.00 | 107.00 | 0.35 | 0.15 | 0.50 | 0.43 | 0.36 | 0.21 | Scott Wolchko | Apr 25th, 2024 06:15PM | Apr 25th, 2024 06:15PM | Fate Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||||||||||
nasdaq:fate | https://www.glassdoor.com?employer_id=601238 | 601238 | Apr 24th, 2024 12:00AM | Open | Fate Therapeutics | Open | Company - Public | Biotechnology | San Diego, CA | 2.60 | 25% | 16% | 31% | 3.90 | 2.70 | 2.70 | 3.30 | 2.30 | 2.30 | 23.00 | 17.00 | 11.00 | 19.00 | 9.00 | 79.00 | 73.00 | 54.00 | 29.114% | 21.519% | 13.924% | 24.051% | 11.392% | 0.00 | 4.00 | 107.00 | 0.35 | 0.15 | 0.50 | 0.43 | 0.36 | 0.21 | Scott Wolchko | Apr 24th, 2024 10:43AM | Apr 24th, 2024 10:43AM | Fate Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:fate | https://www.glassdoor.com?employer_id=601238 | 601238 | Apr 23rd, 2024 12:00AM | Open | Fate Therapeutics | Open | Company - Public | Biotechnology | San Diego, CA | 2.60 | 25% | 16% | 31% | 3.90 | 2.70 | 2.70 | 3.30 | 2.30 | 2.30 | 23.00 | 17.00 | 11.00 | 19.00 | 9.00 | 79.00 | 73.00 | 54.00 | 29.114% | 21.519% | 13.924% | 24.051% | 11.392% | 0.00 | 107.00 | 0.35 | 0.15 | 0.50 | 0.43 | 0.36 | 0.21 | Scott Wolchko | Apr 23rd, 2024 04:17PM | Apr 23rd, 2024 04:17PM | Fate Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||||||||||
nasdaq:fate | https://www.glassdoor.com?employer_id=601238 | 601238 | Apr 21st, 2024 12:00AM | Open | Fate Therapeutics | Open | Company - Public | Biotechnology | San Diego, CA | 2.60 | 25% | 16% | 31% | 3.90 | 2.70 | 2.70 | 3.30 | 2.30 | 2.30 | 23.00 | 16.00 | 11.00 | 19.00 | 9.00 | 78.00 | 73.00 | 54.00 | 29.487% | 20.513% | 14.103% | 24.359% | 11.538% | 0.00 | 106.00 | 0.35 | 0.15 | 0.50 | 0.43 | 0.36 | 0.21 | Scott Wolchko | Apr 21st, 2024 04:19PM | Apr 21st, 2024 04:19PM | Fate Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||||||||||
nasdaq:fate | https://www.glassdoor.com?employer_id=601238 | 601238 | Apr 20th, 2024 12:00AM | Open | Fate Therapeutics | Open | Company - Public | Biotechnology | San Diego, CA | 2.60 | 25% | 16% | 31% | 3.90 | 2.70 | 2.70 | 3.30 | 2.30 | 2.30 | 23.00 | 16.00 | 11.00 | 19.00 | 9.00 | 78.00 | 73.00 | 54.00 | 29.487% | 20.513% | 14.103% | 24.359% | 11.538% | 0.00 | 106.00 | 0.35 | 0.15 | 0.50 | 0.43 | 0.36 | 0.21 | Scott Wolchko | Apr 20th, 2024 04:35PM | Apr 20th, 2024 04:35PM | Fate Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||||||||||
nasdaq:fate | https://www.glassdoor.com?employer_id=601238 | 601238 | Apr 19th, 2024 12:00AM | Open | Fate Therapeutics | Open | Company - Public | Biotechnology | San Diego, CA | 2.60 | 25% | 16% | 31% | 3.90 | 2.70 | 2.70 | 3.30 | 2.30 | 2.30 | 23.00 | 16.00 | 11.00 | 19.00 | 9.00 | 78.00 | 73.00 | 54.00 | 29.487% | 20.513% | 14.103% | 24.359% | 11.538% | 0.00 | 106.00 | 0.35 | 0.15 | 0.50 | 0.43 | 0.36 | 0.21 | Scott Wolchko | Apr 19th, 2024 07:32AM | Apr 19th, 2024 07:32AM | Fate Therapeutics | Health Care | Pharmaceuticals & Biotechnology | |||||||||||
nasdaq:fate | https://www.glassdoor.com?employer_id=601238 | 601238 | Apr 18th, 2024 12:00AM | Open | Fate Therapeutics | Open | Company - Public | Biotechnology | San Diego, CA | 2.60 | 25% | 16% | 31% | 3.90 | 2.70 | 2.70 | 3.30 | 2.30 | 2.30 | 23.00 | 16.00 | 11.00 | 19.00 | 9.00 | 78.00 | 73.00 | 54.00 | 29.487% | 20.513% | 14.103% | 24.359% | 11.538% | 0.00 | 4.00 | 105.00 | 0.35 | 0.15 | 0.50 | 0.43 | 0.36 | 0.21 | Scott Wolchko | Apr 18th, 2024 05:54PM | Apr 18th, 2024 05:54PM | Fate Therapeutics | Health Care | Pharmaceuticals & Biotechnology | ||||||||||
nasdaq:fate | https://www.glassdoor.com?employer_id=601238 | 601238 | Apr 17th, 2024 12:00AM | Open | Fate Therapeutics | Open | Company - Public | Biotechnology | San Diego, CA | 2.60 | 25% | 16% | 31% | 3.90 | 2.70 | 2.70 | 3.30 | 2.30 | 2.30 | 23.00 | 16.00 | 11.00 | 18.00 | 9.00 | 77.00 | 73.00 | 54.00 | 29.87% | 20.779% | 14.286% | 23.377% | 11.688% | 0.00 | 105.00 | 0.35 | 0.15 | 0.50 | 0.43 | 0.36 | 0.21 | Scott Wolchko | Apr 17th, 2024 02:21PM | Apr 17th, 2024 02:21PM | Fate Therapeutics | Health Care | Pharmaceuticals & Biotechnology |